Furthermore, the expression of this intestine-like TF signature could clearly be observed in multiple GEM studies of BO and OAC, and largely absent from GEM studies of squamous cell carcinoma, CRC and breast cancer (Fig. 3E). Here, TF is linked to colorectal carcinoma.